Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
24.50    0.00 (0.00%)
Bid:
23.00
Ask:
26.00
Spread: 3.00 (13.043%)
Market Cap: £11.67m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

New Customer Contract Award & Contract Extension

21 Aug 2018 07:00

RNS Number : 3578Y
Pennant International Group PLC
21 August 2018
 

 

FOR IMMEDIATE RELEASE 21 August 2018

PENNANT INTERNATIONAL GROUP PLC

 

 

Contract Award from New Customer

&

Contract Extension

 

 

Pennant International Group plc ("Pennant" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist engineers in the defence and regulated civilian sectors, is pleased to announce that it has been awarded a contract by a new customer and that it has agreed a beneficial extension to an existing contract with another.

 

New Customer

 

Following a successful tender in open competition, Pennant has been awarded a long-term contract by an undisclosed new government client in the Asia-Pacific region.

 

The contract is for the supply of virtual training software to help air force maintenance engineers practice procedures, functionality and diagnostics in a virtual environment. Pennant will be supplying its Virtual Aircraft Training System ("VATS") (with customer-specific modifications).

 

The VATS product has been undergoing a significant upgrade to its user interface and 3D models in readiness for this sale and for other potential customers. The software will be supplied to the new customer later this year on a perpetual licence. Pennant will be providing ongoing support and maintenance for the software under a ten-year arrangement with the customer.

 

Contract Extension

 

Pennant's Software Services division (home to the OmegaPS software product) has received an order from an existing customer (in the maritime sector) to continue the provision of consultancy and technical documentation services until June 2021.

 

OmegaPS is a logistical support and analysis tool used to reduce the operating costs of major capital equipment in the defence, aerospace and transportation markets.

 

David Clements, Group's Commercial & Risk Director, commented:

 

"We are very pleased to add these two contracts to the order book. The VATS contract was awarded following a very competitive tender process and we look forward to supporting this new customer's training needs over the coming years, whilst the OmegaPS contract extension is testament to this product's market-leading capabilities. Both contracts will contribute to the Group's forward visibility of earnings over a number of years".

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRADBGDIUBDBGIG
Date   Source Headline
12th Jun 20267:00 amRNSMultiyear Auxilium Services Contract Award
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update
22nd Oct 20245:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.